Private Equity

Henri Beaufour’s passing transfers a major Ipsen stake to a charity. We analyze the governance safeguards and what it means when philanthropy enters the boardroom.

Galderma secured stringent EU approval to use its Sculptra biostimulator on the body, targeting a billion-dollar market and setting a new industry benchmark.

In a crowded market, one Vietnamese hotel is using maximalist Italian art to redefine ultra-luxury. A deep dive into a bold business differentiation strategy.

A monumental $31.5 billion contract tasks Peraton with replacing the FAA's aging air traffic control system. Can it succeed where others have failed?

TELUS just secured $2.3 billion in a complex debt offering. We decode the move and what it signals about its high-tech ambitions beyond telecom.

With a high-grade Alaskan asset secured and a $44M war chest, Vizsla Copper is making a bold move in the race for North American resource security.

Baxter is buying back billions in debt, a strategic move to clean its balance sheet. But with operational issues mounting, is it enough to win back investors?

After its DMD drug trial sent shares soaring over 370%, Capricor Therapeutics is raising $75M. A look at the high-stakes strategy to fund a breakthrough.

With $15M in new funding and seasoned mining execs on board, Getty Copper is now debt-free and poised to unlock the potential of its vast copper assets.

A new Texas BBQ joint opens in Airdrie, but it's more than a meal. It’s a story of strategic growth, local entrepreneurship, and building community.

A class action lawsuit against Telix Pharmaceuticals reveals the perilous gap between optimistic corporate disclosures and harsh regulatory setbacks.

Westinghouse's new robotics deal with PROMATION is more than a partnership; it’s a key move in building a Canadian supply chain for a global nuclear revival.

Endeavour Silver's massive convertible note offering slashes debt and funds its giant Pitarrilla project. A savvy move or a dilution risk for investors?

A PE firm's strategic leadership expansion signals a major push to scale capital and master the dual worlds of sustainable and conventional energy investment.

A last-minute regulatory filing by Balyasny Asset Management pulls back the curtain on the multi-billion-dollar battle for Spectris, a key health tech enabler.

A $90M investment in a Colorado town reveals a new strategy for industrial resilience, combining advanced AI with foundational support for its workforce.

How Winemaker of the Year Jesse Katz blends record-setting sales, historic vineyards, and philanthropy to disrupt the ultra-premium wine market.

A regulatory filing shows hedge fund Balyasny's active trading in Avadel Pharma, exposing a merger arbitrage strategy amid a fierce bidding war.

A routine filing reveals a major US asset manager's pivotal 5% stake in UK's NCC Group, potentially shaping the outcome of a major cybersecurity takeover.

Anchin's strategic hire of a top tax partner reveals how specialized expertise in complex sectors like A/E/C is becoming the key to competitive advantage.